Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013062326> ?p ?o ?g. }
- W2013062326 endingPage "1713" @default.
- W2013062326 startingPage "1707" @default.
- W2013062326 abstract "Objectives: To estimate the efficacy and metabolic effects of growth hormone substitution as intravenous pulses together with alanyl-glutamine supplementation and tight blood glucose control in prolonged critical illness. Design: Prospective double-blind, randomized trial with open-label control arm. Setting: Intensive care unit of tertiary level hospital. Patients: Thirty multiple trauma patients (median Injury Severity Score 34). Interventions: Patients were randomized, at day 4 after trauma, to receive intravenous alanyl-glutamine supplementation (0.3 g/kg·day−1 from day 4 until day 17) and intravenous growth hormone (administered days 7–17, full dose 50 μg/kg·day−1 from day 10 onward) (group 1, n = 10) or alanyl-glutamine and placebo (group 2, n = 10). Group 3 (n = 10) received isocaloric isonitrogenous nutrition (proteins 1.5 g/kg·day−1) without alanyl-glutamine. Measurements and Main Results: Cumulative nitrogen balance for the whole study period was −97 ± 38 g of nitrogen for group 1, −193 ± 50 g of nitrogen for group 2, and −198 ± 77 g of nitrogen for group 3 (p < .001). This represents a daily saving of 300 g of lean body mass in group 1. Insulin-mediated glucose disposal, during euglycemic clamp, as a measure of insulin sensitivity, significantly worsened between days 4 and 17 in group 1 but improved in groups 2 and 3. Group 1 required significantly more insulin to control blood glucose, resulting in higher insulinemia (∼70 mIU in group 1 vs. ∼25 mIU in groups 2 and 3). Despite this, growth hormone treatment caused an increase in plasma nonesterified fatty acid (∼0.5–0.6 mM in group 1 in comparison with ∼0.2–0.3 mM in groups 2 and 3) but did not influence lipid oxidation. There were no differences in morbidity, mortality, or 6-month outcome among the groups. Conclusions: Treatment with frequent intravenous pulses of low-dose growth hormone together with alanyl-glutamine supplementation improves nitrogen economy in patients with prolonged critical illness after multiple trauma but worsens insulin sensitivity. Tight blood glucose control is possible but requires higher doses of insulin." @default.
- W2013062326 created "2016-06-24" @default.
- W2013062326 creator A5017669903 @default.
- W2013062326 creator A5018653083 @default.
- W2013062326 creator A5030043640 @default.
- W2013062326 creator A5046304275 @default.
- W2013062326 creator A5047015196 @default.
- W2013062326 creator A5058626976 @default.
- W2013062326 creator A5077385632 @default.
- W2013062326 creator A5081292210 @default.
- W2013062326 date "2008-06-01" @default.
- W2013062326 modified "2023-10-18" @default.
- W2013062326 title "Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: Effects on nitrogen balance, insulin resistance, and substrate oxidation*" @default.
- W2013062326 cites W1886318705 @default.
- W2013062326 cites W1956418669 @default.
- W2013062326 cites W1972378603 @default.
- W2013062326 cites W1973956216 @default.
- W2013062326 cites W1980717583 @default.
- W2013062326 cites W1997095142 @default.
- W2013062326 cites W1999693766 @default.
- W2013062326 cites W2002775452 @default.
- W2013062326 cites W2008508452 @default.
- W2013062326 cites W2032910734 @default.
- W2013062326 cites W2046222793 @default.
- W2013062326 cites W2075323540 @default.
- W2013062326 cites W2083499159 @default.
- W2013062326 cites W2089471666 @default.
- W2013062326 cites W2096863665 @default.
- W2013062326 cites W2106515336 @default.
- W2013062326 cites W2115285670 @default.
- W2013062326 cites W2159103120 @default.
- W2013062326 cites W2165740328 @default.
- W2013062326 cites W3142972004 @default.
- W2013062326 cites W3144696145 @default.
- W2013062326 cites W4293108385 @default.
- W2013062326 cites W4376849282 @default.
- W2013062326 doi "https://doi.org/10.1097/ccm.0b013e318174d499" @default.
- W2013062326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18496372" @default.
- W2013062326 hasPublicationYear "2008" @default.
- W2013062326 type Work @default.
- W2013062326 sameAs 2013062326 @default.
- W2013062326 citedByCount "36" @default.
- W2013062326 countsByYear W20130623262012 @default.
- W2013062326 countsByYear W20130623262013 @default.
- W2013062326 countsByYear W20130623262014 @default.
- W2013062326 countsByYear W20130623262015 @default.
- W2013062326 countsByYear W20130623262016 @default.
- W2013062326 countsByYear W20130623262017 @default.
- W2013062326 countsByYear W20130623262018 @default.
- W2013062326 countsByYear W20130623262019 @default.
- W2013062326 countsByYear W20130623262020 @default.
- W2013062326 countsByYear W20130623262021 @default.
- W2013062326 crossrefType "journal-article" @default.
- W2013062326 hasAuthorship W2013062326A5017669903 @default.
- W2013062326 hasAuthorship W2013062326A5018653083 @default.
- W2013062326 hasAuthorship W2013062326A5030043640 @default.
- W2013062326 hasAuthorship W2013062326A5046304275 @default.
- W2013062326 hasAuthorship W2013062326A5047015196 @default.
- W2013062326 hasAuthorship W2013062326A5058626976 @default.
- W2013062326 hasAuthorship W2013062326A5077385632 @default.
- W2013062326 hasAuthorship W2013062326A5081292210 @default.
- W2013062326 hasConcept C120863210 @default.
- W2013062326 hasConcept C121332964 @default.
- W2013062326 hasConcept C126322002 @default.
- W2013062326 hasConcept C134018914 @default.
- W2013062326 hasConcept C142724271 @default.
- W2013062326 hasConcept C147583825 @default.
- W2013062326 hasConcept C168563851 @default.
- W2013062326 hasConcept C204787440 @default.
- W2013062326 hasConcept C27081682 @default.
- W2013062326 hasConcept C2776376669 @default.
- W2013062326 hasConcept C2777391703 @default.
- W2013062326 hasConcept C2779306644 @default.
- W2013062326 hasConcept C2779349466 @default.
- W2013062326 hasConcept C515207424 @default.
- W2013062326 hasConcept C537208039 @default.
- W2013062326 hasConcept C55493867 @default.
- W2013062326 hasConcept C62520636 @default.
- W2013062326 hasConcept C71924100 @default.
- W2013062326 hasConcept C8101879 @default.
- W2013062326 hasConcept C86803240 @default.
- W2013062326 hasConcept C90924648 @default.
- W2013062326 hasConceptScore W2013062326C120863210 @default.
- W2013062326 hasConceptScore W2013062326C121332964 @default.
- W2013062326 hasConceptScore W2013062326C126322002 @default.
- W2013062326 hasConceptScore W2013062326C134018914 @default.
- W2013062326 hasConceptScore W2013062326C142724271 @default.
- W2013062326 hasConceptScore W2013062326C147583825 @default.
- W2013062326 hasConceptScore W2013062326C168563851 @default.
- W2013062326 hasConceptScore W2013062326C204787440 @default.
- W2013062326 hasConceptScore W2013062326C27081682 @default.
- W2013062326 hasConceptScore W2013062326C2776376669 @default.
- W2013062326 hasConceptScore W2013062326C2777391703 @default.
- W2013062326 hasConceptScore W2013062326C2779306644 @default.
- W2013062326 hasConceptScore W2013062326C2779349466 @default.
- W2013062326 hasConceptScore W2013062326C515207424 @default.
- W2013062326 hasConceptScore W2013062326C537208039 @default.
- W2013062326 hasConceptScore W2013062326C55493867 @default.